154 related articles for article (PubMed ID: 15962839)
1. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice.
Mahaseth H; Vercellotti GM; Welch TE; Bowlin PR; Sonbol KM; Hsia CJ; Li M; Bischof JC; Hebbel RP; Belcher JD
J Lab Clin Med; 2005 Apr; 145(4):204-11. PubMed ID: 15962839
[TBL] [Abstract][Full Text] [Related]
2. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice.
Belcher JD; Mahaseth H; Welch TE; Vilback AE; Sonbol KM; Kalambur VS; Bowlin PR; Bischof JC; Hebbel RP; Vercellotti GM
Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2715-25. PubMed ID: 15665055
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice.
Kaul DK; Liu XD; Choong S; Belcher JD; Vercellotti GM; Hebbel RP
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H293-301. PubMed ID: 15001449
[TBL] [Abstract][Full Text] [Related]
4. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants.
Kaul DK; Liu XD; Zhang X; Ma L; Hsia CJ; Nagel RL
Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H167-75. PubMed ID: 16443674
[TBL] [Abstract][Full Text] [Related]
6. Disrupting the vicious cycle created by NOX activation in sickle erythrocytes exposed to hypoxia/reoxygenation prevents adhesion and vasoocclusion.
MacKinney A; Woska E; Spasojevic I; Batinic-Haberle I; Zennadi R
Redox Biol; 2019 Jul; 25():101097. PubMed ID: 30661992
[TBL] [Abstract][Full Text] [Related]
7. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy.
Kalambur VS; Mahaseth H; Bischof JC; Kielbik MC; Welch TE; Vilbäck A; Swanlund DJ; Hebbel RP; Belcher JD; Vercellotti GM
Am J Hematol; 2004 Oct; 77(2):117-25. PubMed ID: 15389823
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.
Kaul DK; Hebbel RP
J Clin Invest; 2000 Aug; 106(3):411-20. PubMed ID: 10930444
[TBL] [Abstract][Full Text] [Related]
9. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.
Belcher JD; Mahaseth H; Welch TE; Otterbein LE; Hebbel RP; Vercellotti GM
J Clin Invest; 2006 Mar; 116(3):808-16. PubMed ID: 16485041
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease.
Belcher JD; Vineyard JV; Bruzzone CM; Chen C; Beckman JD; Nguyen J; Steer CJ; Vercellotti GM
J Mol Med (Berl); 2010 Jul; 88(7):665-75. PubMed ID: 20306336
[TBL] [Abstract][Full Text] [Related]
11. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice.
Aufradet E; DeSouza G; Bourgeaux V; Bessaad A; Campion Y; Canet-Soulas E; Pialoux V; Chirico EN; Chevrier AM; Godfrin Y; Martin C
Clin Hemorheol Microcirc; 2013 Jan; 54(3):297-312. PubMed ID: 23696418
[TBL] [Abstract][Full Text] [Related]
13. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
Zhao Y; Schwartz EA; Palmer GM; Zennadi R
FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice.
Wood KC; Hebbel RP; Granger DN
FASEB J; 2005 Jun; 19(8):989-91. PubMed ID: 15923406
[TBL] [Abstract][Full Text] [Related]
15. Polynitroxyl albumin plus tempol attenuates liver injury and inflammation after hepatic ischemia and reperfusion.
Blonder JM; McCalden TA; Hsia CJ; Billings RE
Life Sci; 2000 Nov; 67(26):3231-9. PubMed ID: 11191630
[TBL] [Abstract][Full Text] [Related]
16. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
17. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
Front Immunol; 2020; 11():613278. PubMed ID: 33542720
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with polynitroxyl albumin (PNA) inhibits ischemia-reperfusion induced leukocyte-endothelial cell adhesion.
Russell J; Okayama N; Alexander JS; Granger DN; Hsia CJ
Free Radic Biol Med; 1998 Jul; 25(2):153-9. PubMed ID: 9667490
[TBL] [Abstract][Full Text] [Related]
19. Transgenic sickle mice have vascular inflammation.
Belcher JD; Bryant CJ; Nguyen J; Bowlin PR; Kielbik MC; Bischof JC; Hebbel RP; Vercellotti GM
Blood; 2003 May; 101(10):3953-9. PubMed ID: 12543857
[TBL] [Abstract][Full Text] [Related]
20. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
